Gao X, Tang M, Li J, Ma J, Liu Z, Liu W
Respir Res. 2025; 26(1):69.
PMID: 40016745
PMC: 11869626.
DOI: 10.1186/s12931-025-03151-7.
Costamagna A, Balzani E, Marro M, Simonato E, Burello A, Rinaldi M
Transpl Int. 2025; 38:13794.
PMID: 39944219
PMC: 11815944.
DOI: 10.3389/ti.2025.13794.
Li C, Gao P, Zhuang F, Wang T, Wang Z, Wu G
Research (Wash D C). 2024; 7:0473.
PMID: 39268501
PMC: 11391482.
DOI: 10.34133/research.0473.
Niroomand A, Nita G, Lindstedt S
Transpl Int. 2024; 37:13215.
PMID: 39267617
PMC: 11390383.
DOI: 10.3389/ti.2024.13215.
Braithwaite S, Berg E, de Heer L, Jennekens J, Neyrinck A, van Hooijdonk E
Front Transplant. 2024; 3:1422088.
PMID: 39229386
PMC: 11368876.
DOI: 10.3389/frtra.2024.1422088.
The Role of Ficolins in Lung Injury.
Zhao M, Tan X, Wu X
J Innate Immun. 2024; 16(1):440-450.
PMID: 39159606
PMC: 11521482.
DOI: 10.1159/000540954.
Impact of Pre-Transplant Left Ventricular Diastolic Pressure on Primary Graft Dysfunction after Lung Transplantation: A Narrative Review.
Henry J, Carlier F, Higny J, Benoit M, Xhaet O, Blommaert D
Diagnostics (Basel). 2024; 14(13).
PMID: 39001230
PMC: 11240543.
DOI: 10.3390/diagnostics14131340.
Pulmonary transplant complications: a radiologic review.
Friedlander S, Pogatchnik B, Furuya Y, Allen T
J Cardiothorac Surg. 2024; 19(1):270.
PMID: 38702686
PMC: 11067284.
DOI: 10.1186/s13019-024-02731-w.
Heparin-free veno-arterial extracorporeal membrane oxygenation in lung transplantation: a retrospective cohort study.
Huang Z, Zheng J, Wang M, Zeng S, Huang M, Peng S
J Cardiothorac Surg. 2024; 19(1):255.
PMID: 38643128
PMC: 11031941.
DOI: 10.1186/s13019-024-02721-y.
The endothelium: gatekeeper to lung ischemia-reperfusion injury.
Ta H, Kuppusamy M, Sonkusare S, Roeser M, Laubach V
Respir Res. 2024; 25(1):172.
PMID: 38637760
PMC: 11027545.
DOI: 10.1186/s12931-024-02776-4.
Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation.
Jenkins J, Verdiner R, Omar A, Farina J, Wilson R, DCunha J
Front Immunol. 2024; 15:1341675.
PMID: 38380332
PMC: 10876853.
DOI: 10.3389/fimmu.2024.1341675.
Seeing through the Smoke: Clearing Up the Link between Donor Smoke Exposure and Lung Transplant Outcomes.
Bermea R, Keller B
Am J Respir Crit Care Med. 2023; 209(1):12-13.
PMID: 38099727
PMC: 10870873.
DOI: 10.1164/rccm.202310-1803ED.
Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates.
Diamond J, Anderson M, Cantu E, S Clausen E, Shashaty M, Kalman L
J Heart Lung Transplant. 2023; 43(4):633-641.
PMID: 38065239
PMC: 10947904.
DOI: 10.1016/j.healun.2023.11.019.
Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts.
Cerier E, Kurihara C, Kaiho T, Toyoda T, Manerikar A, Kandula V
Am J Transplant. 2023; 24(4):577-590.
PMID: 37977230
PMC: 10982049.
DOI: 10.1016/j.ajt.2023.11.006.
Pulmonary, circulatory and renal considerations in the early postoperative management of the lung transplant recipient.
Girgis R, Hadley R, Murphy E
Glob Cardiol Sci Pract. 2023; 2023(3):e202318.
PMID: 37575284
PMC: 10422876.
DOI: 10.21542/gcsp.2023.18.
Management of primary graft dysfunction after lung transplantation with extracorporeal life support: an evidence-based review.
Luu H, Santos J, Isaza E, Brzezinski M, Kukreja J
J Thorac Dis. 2023; 15(7):4090-4100.
PMID: 37559633
PMC: 10407492.
DOI: 10.21037/jtd-22-1387.
Current Perspectives and Future Directions in Lung Transplantation.
Verzelloni Sef A, Sef D, Trkulja V, Marczin N
Life (Basel). 2023; 13(7).
PMID: 37511807
PMC: 10381398.
DOI: 10.3390/life13071432.
Mesenchymal Stromal Cell Therapy in Lung Transplantation.
Nykanen A, Liu M, Keshavjee S
Bioengineering (Basel). 2023; 10(6).
PMID: 37370659
PMC: 10295637.
DOI: 10.3390/bioengineering10060728.
Primary graft dysfunction following lung transplantation: From pathogenesis to future frontiers.
Avtaar Singh S, Das De S, Al-Adhami A, Singh R, Hopkins P, Curry P
World J Transplant. 2023; 13(3):58-85.
PMID: 36968136
PMC: 10037231.
DOI: 10.5500/wjt.v13.i3.58.
Effect of targeted coagulopathy management and 5% albumin as volume replacement therapy during lung transplantation on allograft function: a secondary analysis of a randomized clinical trial.
Vajter J, Vachtenheim Jr J, Prikrylova Z, Berousek J, Vymazal T, Lischke R
BMC Pulm Med. 2023; 23(1):80.
PMID: 36894877
PMC: 9996868.
DOI: 10.1186/s12890-023-02372-0.
